|
Post by peppy on Jun 4, 2017 14:44:46 GMT -5
Here is my latest theory on WHY AMGEN is going to BUY MNKD soon .... I am guessing AMGEN is still negotiating with MNKD about terms of BUYOUT .....but until any deal is signed MNKD can make any deal that is wants to. The BIOMM deal was signed by Matt ....maybe this was done to speed up AMGENs final offer. Every country that signed a deal will be a revenue loss for AMGEN. I think the AMGEN deal is done ....after the BIOMM announcement suddenly Matt is out and Mike is IN. This will stop any further deals from being signed before the BUYOUT. I bet the end is near for Shorts ..... If as perhaps has been suggested, Mike C was hired by MNKD because Amgen was interested and wanted to assess the situation....... or some version of that story. If the other MNKD hires from AMGEN two other? the international person and was it Ray? So if: (Kuka and all,) when would any agreement of sorts need to be disclosed? If the answer is when a deal is signed, could hiring and planning for this be done, and then..... surprise, we have an agreement? If, big if, I wonder what the actual laws are with this type of story.
The suggestion is, all this interest and hires from Amgen.... and nothing disclosed.....
|
|
|
Post by mydogskip on Jun 4, 2017 16:49:21 GMT -5
Companies don't tell their execs to quit and go interview for another company to "investigate."
That's just silly speculation by those who do not know what they are writing about and shows a very poor understanding of how businesses work.
If Amgen, or any company, was truly interested in another biotech, they do their due diligence by meeting with the company etc and work on a deal first. That either ends up in a partnership or offer for a buyout.
There isn't some secretive play as some of you are foolishly stating.
And I can tell you for certain that Mike isn't an Amgen plant. He left Amgen like many other people when they don't see any future at their current employer. This I know for a fact.
While anything is possible, this notion that Amgen is going to buy out Mannkind is pure speculation.
Besides, AMGEN already has struck out on diabetes when their deal with Array went sour years back.
On a side note, the fact that there was no PR from Mannkind thanking Matt for his efforts at Mannkind is telling.
|
|
|
Post by nylefty on Jun 4, 2017 17:31:28 GMT -5
On a side note, the fact that there was no PR from Mannkind thanking Matt for his efforts at Mannkind is telling. Saying they're "extremely grateful" for his "committed service" isn't thanking him for his efforts? investors.mannkindcorp.com/releasedetail.cfm?ReleaseID=1028218Kent Kresa, Chairman of the Board, said, "The Board is extremely grateful to Matt for his committed service to the company over the past nine years. Matt successfully set the foundation for the company during its transition into a commercial entity and effectively prepared Michael to be his successor."
|
|
|
Post by lennymnkd on Jun 4, 2017 17:34:02 GMT -5
Lot of money in the diabetic space , might be worth a second try / especially, and I mean especially! With technosphere .. as far as Amgen / Mnkd dealings ... share price .. along with options for Employee enticement might be a consideration... to keep this under the radar and play it the way they might have .
|
|
|
Post by babaoriley on Jun 4, 2017 19:19:05 GMT -5
Companies don't tell their execs to quit and go interview for another company to "investigate." That's just silly speculation by those who do not know what they are writing about and shows a very poor understanding of how businesses work. If Amgen, or any company, was truly interested in another biotech, they do their due diligence by meeting with the company etc and work on a deal first. That either ends up in a partnership or offer for a buyout. There isn't some secretive play as some of you are foolishly stating. And I can tell you for certain that Mike isn't an Amgen plant. He left Amgen like many other people when they don't see any future at their current employer. This I know for a fact. While anything is possible, this notion that Amgen is going to buy out Mannkind is pure speculation. Besides, AMGEN already has struck out on diabetes when their deal with Array went sour years back. On a side note, the fact that there was no PR from Mannkind thanking Matt for his efforts at Mannkind is telling. yourdogskip, I believe you are correct, very, very few people on this board actually know what they are writing about. If you are posting on this board, you have to consider that very seriously.
|
|
|
Post by nadathing on Jun 4, 2017 19:25:12 GMT -5
I have to laugh when I read posts speculating that there was a plot between AMGN and MNKD to have Mike and others join MNKD prior to a BO. Just plain nuts IMO.
|
|
|
Post by sophie on Jun 4, 2017 19:32:07 GMT -5
I picked the end of summer because that is when Kula said the AMGEN buyout would happen. I am happy to make that announced rather than happened if it makes Kula more willing to play. The problem with discussions like the AMGEN one is that it is not actionable. Someone very assertively announces that AMGEN will buy Mannkind and can never be proved wrong because it is always going to happen tomorrow, next month, next year. It is always "jam tomorrow". Case in point. mnkd.proboards.com/post/64846/threadKuka been trolling this board for a loooooooooong time.
|
|
|
Post by kuka on Jun 4, 2017 20:55:29 GMT -5
|
|
|
Post by agedhippie on Jun 4, 2017 21:18:56 GMT -5
Microsoft sent over their CEO before buying Nokia Steve Ballmer??? Lol. Come on - what about that $100 bet on Amgen? Not so certain now?
|
|
|
Post by mydogskip on Jun 4, 2017 21:27:18 GMT -5
Companies don't tell their execs to quit and go interview for another company to "investigate." That's just silly speculation by those who do not know what they are writing about and shows a very poor understanding of how businesses work. If Amgen, or any company, was truly interested in another biotech, they do their due diligence by meeting with the company etc and work on a deal first. That either ends up in a partnership or offer for a buyout. There isn't some secretive play as some of you are foolishly stating. And I can tell you for certain that Mike isn't an Amgen plant. He left Amgen like many other people when they don't see any future at their current employer. This I know for a fact. While anything is possible, this notion that Amgen is going to buy out Mannkind is pure speculation. Besides, AMGEN already has struck out on diabetes when their deal with Array went sour years back. On a side note, the fact that there was no PR from Mannkind thanking Matt for his efforts at Mannkind is telling. yourdogskip, I believe you are correct, very, very few people on this board actually know what they are writing about. If you are posting on this board, you have to consider that very seriously. And why I rarely post any longer. This is the new Yahoo board.
|
|
|
Post by mnkdfann on Jun 4, 2017 21:30:26 GMT -5
Microsoft sent over their CEO before buying Nokia Steve Ballmer??? Lol. I believe he meant that Microsoft sent their employee Stephen Elop to infiltrate Nokia / serve as Nokia's CEO, prior to buying it.
|
|
|
Post by kuka on Jun 4, 2017 21:34:34 GMT -5
Yo.... I dont listed to FUDSTERS .... MY MNKD holdings tell the story about what I think about its future... People with Skin in the game are supposed to care ...those with NO investment are just FUD posters ...many are paid to create a smokescreen
|
|
|
Post by sophie on Jun 4, 2017 23:09:14 GMT -5
I keep seeing people write spreading fear as being a bad thing. A little bit of fear is healthy in my eyes. www.youtube.com/watch?v=H28029McJgcI always did have trouble getting drunk on Kool-Aid though.
|
|
|
Post by straightly on Jun 4, 2017 23:51:30 GMT -5
Companies don't tell their execs to quit and go interview for another company to "investigate." That's just silly speculation by those who do not know what they are writing about and shows a very poor understanding of how businesses work. If Amgen, or any company, was truly interested in another biotech, they do their due diligence by meeting with the company etc and work on a deal first. That either ends up in a partnership or offer for a buyout. There isn't some secretive play as some of you are foolishly stating. And I can tell you for certain that Mike isn't an Amgen plant. He left Amgen like many other people when they don't see any future at their current employer. This I know for a fact. While anything is possible, this notion that Amgen is going to buy out Mannkind is pure speculation. Besides, AMGEN already has struck out on diabetes when their deal with Array went sour years back. On a side note, the fact that there was no PR from Mannkind thanking Matt for his efforts at Mannkind is telling. "Is teiing" of what?
|
|
|
Post by peppy on Jun 5, 2017 0:20:45 GMT -5
Companies don't tell their execs to quit and go interview for another company to "investigate." That's just silly speculation by those who do not know what they are writing about and shows a very poor understanding of how businesses work. If Amgen, or any company, was truly interested in another biotech, they do their due diligence by meeting with the company etc and work on a deal first. That either ends up in a partnership or offer for a buyout. There isn't some secretive play as some of you are foolishly stating. And I can tell you for certain that Mike isn't an Amgen plant. He left Amgen like many other people when they don't see any future at their current employer. This I know for a fact. While anything is possible, this notion that Amgen is going to buy out Mannkind is pure speculation. Besides, AMGEN already has struck out on diabetes when their deal with Array went sour years back. On a side note, the fact that there was no PR from Mannkind thanking Matt for his efforts at Mannkind is telling. yourdogskip, I believe you are correct, very, very few people on this board actually know what they are writing about. If you are posting on this board, you have to consider that very seriously. Great
|
|